Deprescribing antihypertensives in patients with multimorbidity
Abstract
Deprescribing preventative medications such as antihypertensives may reduce adverse events in some older adults, leading to improved quality of life.
The Optimising Treatment for Mild Systolic Hypertension in the Elderly (OPTIMISE) trial examined the safety and efficacy of antihypertensive deprescribing in older patients taking more than one treatment for hypertension.
This article discusses the findings of the study and their implications for clinical practice.
Citations
James P Sheppard AND Rupert A Payne. Deprescribing antihypertensives in patients with multimorbidity. Prescriber October 2020
Sponsorship: Supported by the NIHR (CLAHRC)
Page last reviewed: 12 June, 2025
Metadata
Author(s): External author(s) only
Collection: 123456789/216
Subject(s): De-prescribing, Hypertension, Multi Morbidity, Older People
Format(s): Article
Date issued: 2020-10
ISSN: 09596682
ID: 651